JUN 20, 2019 07:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Keynote Presentation: The Impact of Patient-to-Patient Variability on Combination Cancer Therapy and Precision Oncology

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Systems Biologist, Laboratory of Systems Pharmacology, Harvard Medical School
    Biography
      Adam Palmer is a systems biologist working on the analysis and design of combination cancer therapies. Adam applies experiments, theory, and analysis of data from clinical trials of cancer therapies, with a particular interest in the origins and therapeutic consequences of cell-to-cell and patient-to-patient heterogeneity in cancers. Adam is presently a postdoctoral fellow with Peter Sorger in the Laboratory of Systems Pharmacology at Harvard Medical School. Previously, Adam completed his Ph.D in Systems Biology at Harvard University with Roy Kishony, researching the relationships between mechanisms of drug action and the evolution of antibiotic resistance.

    Abstract:

    Most cancer therapies have highly variable activity from one patient to another, with only a fraction of patients’ cancers responding to a given treatment. In many types of cancer, combination therapies can improve the probability of response. Since 1961 it was known that combinations of individually active therapies can be expected to improve response rate to some degree simply by increasing each patient’s chance of receiving at least one personally effective therapy. Here I describe recent analyses of contemporary combination therapies showing that this phenomenon of patient-to-patient variability in single-drug activity accounts for the clinical activity of many approved combination cancer therapies. These results highlight widespread opportunities to make more precise use of cancer therapies both individually and in combinations.

    Learning Objectives: 

    1. How patient-to-patient variability in response to individual cancer therapies affects responses to combinations of cancer therapies, and the implications for precision medicine in oncology.
    2. How to calculate the 'independent effect' Progression Free Survival distribution for a combination of cancer therapies, which can be used to analyze clinical trial results, and to predict the activity of combinations of independently acting drugs.


    Show Resources
    You May Also Like
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    FEB 26, 2019 09:00 AM PST
    C.E. CREDITS
    FEB 26, 2019 09:00 AM PST
    DATE:  February 26, 2019TIME:   9:00am PST, 12:00pm EST In an era of increasingly high-throughput, large-scale biology, with companies, government and non-prof...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    MAR 05, 2019 09:00 AM PST
    C.E. CREDITS
    MAR 05, 2019 09:00 AM PST
    DATE:  March 5, 2019TIME:  09:00am PST, 12:00pm EST MicroRNA(miRNA) are short non-coding single stranded RNA molecules that regulate gene expression at the post tran...
    JUN 05, 2019 05:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    NOV 21, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 21, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 21, 2019TIME: 9:00am PST, 12:00pm EST Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobu...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds